Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-02-12 Sale |
2025-03-04 4:08 pm |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
29,991 | $0 | $0 | 114,156 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-07 Tax Withholding |
2025-04-09 6:35 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
480 | $4.44 | 176,176 (Direct) |
View |
2025-03-06 Option Award |
2025-03-10 4:17 pm |
N/A 2032-03-05 |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
62,500 | $0 | 426,269 (Direct) |
View |
2025-03-01 Tax Withholding |
2025-03-04 4:08 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
313 | $7.48 | 114,156 (Direct) |
View |
2024-12-08 Tax Withholding |
2024-12-10 4:02 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
18,674 | $9.01 | 144,460 (Direct) |
View |
2024-06-08 Tax Withholding |
2024-06-11 4:10 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
1,249 | $6.19 | 163,134 (Direct) |
View |
2024-04-07 Tax Withholding |
2024-04-09 7:27 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
585 | $2.29 | 164,383 (Direct) |
View |
2024-03-13 Option Award |
2024-03-15 5:16 pm |
N/A 2031-03-12 |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
125,000 | $0 | 187,113 (Direct) |
View |
2024-03-01 Tax Withholding |
2024-03-04 6:43 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
381 | $3.39 | 164,968 (Direct) |
View |
2023-06-09 Option Award |
2023-06-13 9:22 pm |
N/A 2030-06-08 |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
46,155 | $0 | 227,462 (Direct) |
View |
2023-04-07 Tax Withholding |
2023-04-10 7:41 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
480 | $0 | 120,154 (Direct) |
View |
2023-03-02 Option Award |
2023-03-06 7:36 pm |
N/A 2030-03-01 |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
11,538 | $0 | 151,017 (Direct) |
View |
2022-12-09 Option Award |
2022-12-13 5:20 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
96,310 | $0 | 108,136 (Direct) |
View |
2022-04-08 Option Award |
2022-04-12 4:06 pm |
N/A 2029-04-07 |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
23,651 | $42.28 | 35,477 (Direct) |
View |
2022-04-08 Option Award |
2022-04-12 4:06 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
5,913 | $0 | 35,477 (Direct) |
View |
Ownership |
2022-03-25 3:17 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
0 | $0 | 0 (Direct) |
View |